Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

548
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
548

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Individual and combined effects of wheel running and ischemic preconditioning in protecting the rat heart from reperfusion injury.

American journal of physiology. Cell physiology·2026
Same author

The role of uridine diphosphate glucuronosyltransferase 1A4 polymorphisms on posaconazole exposure.

Pharmacogenetics and genomics·2026
Same author

A conserved sRNA regulates mucin adhesion and gut colonization across the Enterococcaceae.

bioRxiv : the preprint server for biology·2025
Same author

Longitudinal Gut Microbiome Changes Associated with Transitions from <i>C. difficile</i> Negative to <i>C. difficile</i> Positive on Surveillance Tests.

Microorganisms·2025
Same author

Gut microbiota and metabolites drive chronic sickle cell disease pain in mice.

Cell host & microbe·2025
Same author

Radiation-Induced Cardiotoxicity in Hypertensive Salt-Sensitive Rats: A Feasibility Study.

Life (Basel, Switzerland)·2025

Related Experiment Video

Updated: Mar 16, 2026

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

4.7K

Intestinal Microbial Metabolites Are Linked to Severity of Myocardial Infarction in Rats.

Vy Lam1, Jidong Su1, Anna Hsu2

  • 1Division of Cardiothoracic Surgery, Medical College of Wisconsin, Milwaukee, WI, United States of America.

Plos One
|August 10, 2016
PubMed
Summary

Gut bacteria metabolites impact heart attack severity. Altering gut microbes with antibiotics reduced myocardial infarction size in rats, a protective effect reversed by specific amino acid metabolites.

More Related Videos

Acute Myocardial Infarction in Rats
07:45

Acute Myocardial Infarction in Rats

Published on: February 16, 2011

55.0K
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
07:23

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

7.5K

Related Experiment Videos

Last Updated: Mar 16, 2026

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

4.7K
Acute Myocardial Infarction in Rats
07:45

Acute Myocardial Infarction in Rats

Published on: February 16, 2011

55.0K
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
07:23

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

7.5K

Area of Science:

  • Microbiology
  • Cardiovascular Science
  • Metabolomics

Background:

  • The gut microbiota significantly influences host physiology and disease.
  • The role of microbial metabolites in cardiovascular disease severity remains incompletely understood.
  • Intestinal microbiota metabolites may enter systemic circulation and affect organ function.

Purpose of the Study:

  • To investigate the link between low molecular weight metabolites from intestinal microbiota and myocardial infarction severity.
  • To determine if antibiotic-induced alterations in gut microbiota affect myocardial infarction outcomes.
  • To elucidate the mechanisms by which microbial metabolites influence cardiac injury.

Main Methods:

  • Antibiotic treatment (vancomycin or antibiotic cocktail) in rats to alter gut microbiota.
  • Mass spectrometry-based metabolomic profiling of plasma to identify microbial metabolites.
  • Induction of myocardial infarction and assessment of infarct size.
  • Administration of amino acid metabolites and use of kinase/channel inhibitors to probe mechanisms.

Main Results:

  • Antibiotic treatments significantly altered host metabolism, particularly aromatic amino acid catabolism.
  • Both antibiotic treatments reduced myocardial infarction severity by 27% and 29%.
  • Administration of microbial amino acid metabolites abolished the cardioprotective effect of vancomycin.
  • Inhibition of specific signaling pathways (Src kinase, Akt/PI3K, MAPK) and KATP channels abrogated vancomycin's cardioprotection.

Conclusions:

  • Gut microbiota-derived metabolites are linked to myocardial infarction severity in rats.
  • These metabolites appear to exert cardioprotective effects by interacting with cell surface receptors and activating specific signaling pathways.
  • Findings suggest potential for novel diagnostic and therapeutic strategies targeting the gut microbiota for cardiovascular disease prevention.